These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36372297)

  • 1. Resolvins Lipid Mediators: Potential Therapeutic Targets in Alzheimer and Parkinson Disease.
    Anand S; Azam Ansari M; Kumaraswamy Sukrutha S; Alomary MN; Anwar Khan A; Elderdery AY
    Neuroscience; 2022 Dec; 507():139-148. PubMed ID: 36372297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of Inflammation in Neurodegenerative Diseases: The Role of Resolvins.
    Chamani S; Bianconi V; Tasbandi A; Pirro M; Barreto GE; Jamialahmadi T; Sahebkar A
    Mediators Inflamm; 2020; 2020():3267172. PubMed ID: 32308554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging roles of resolvins in the resolution of inflammation and pain.
    Ji RR; Xu ZZ; Strichartz G; Serhan CN
    Trends Neurosci; 2011 Nov; 34(11):599-609. PubMed ID: 21963090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoxins and new lipid mediators in the resolution of inflammation.
    Schwab JM; Serhan CN
    Curr Opin Pharmacol; 2006 Aug; 6(4):414-20. PubMed ID: 16750421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation.
    Weylandt KH; Chiu CY; Gomolka B; Waechter SF; Wiedenmann B
    Prostaglandins Other Lipid Mediat; 2012 Mar; 97(3-4):73-82. PubMed ID: 22326554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications for eicosapentaenoic acid- and docosahexaenoic acid-derived resolvins as therapeutics for arthritis.
    Souza PR; Norling LV
    Eur J Pharmacol; 2016 Aug; 785():165-173. PubMed ID: 26165764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of lipoxins and resolvins in human leukocytes.
    Kahnt AS; Schebb NH; Steinhilber D
    Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106726. PubMed ID: 36878381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EPA- and DHA-derived resolvins' actions in inflammatory bowel disease.
    Schwanke RC; Marcon R; Bento AF; Calixto JB
    Eur J Pharmacol; 2016 Aug; 785():156-164. PubMed ID: 26325092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids.
    Zhang MJ; Spite M
    Annu Rev Nutr; 2012 Aug; 32():203-27. PubMed ID: 22404117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection.
    Gallo CG; Fiorino S; Posabella G; Antonacci D; Tropeano A; Pausini E; Pausini C; Guarniero T; Hong W; Giampieri E; Corazza I; Loiacono R; Loggi E; de Biase D; Zippi M; Lari F; Zancanaro M
    Prostaglandins Other Lipid Mediat; 2022 Apr; 159():106619. PubMed ID: 35032665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-resolving mediators produced from EPA and DHA: Overview of the pathways involved and their mechanisms in metabolic syndrome and related liver diseases.
    López-Vicario C; Rius B; Alcaraz-Quiles J; García-Alonso V; Lopategi A; Titos E; Clària J
    Eur J Pharmacol; 2016 Aug; 785():133-143. PubMed ID: 25987424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory and proresolving lipid mediators.
    Serhan CN; Yacoubian S; Yang R
    Annu Rev Pathol; 2008; 3():279-312. PubMed ID: 18233953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Endogenous Eicosapentaenoic Acid and Docosahexaenoic Acid-Derived Resolvins in Systemic Sclerosis.
    Avanoǧlu Güler A; Rossi FW; Bellando-Randone S; Prevete N; Tufan A; Manetti M; de Paulis A; Matucci-Cerinic M
    Front Immunol; 2020; 11():1249. PubMed ID: 32636845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins.
    Serhan CN
    Curr Opin Clin Nutr Metab Care; 2005 Mar; 8(2):115-21. PubMed ID: 15716788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation.
    Duvall MG; Levy BD
    Eur J Pharmacol; 2016 Aug; 785():144-155. PubMed ID: 26546247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolvins as proresolving inflammatory mediators in cardiovascular disease.
    Capó X; Martorell M; Busquets-Cortés C; Tejada S; Tur JA; Pons A; Sureda A
    Eur J Med Chem; 2018 Jun; 153():123-130. PubMed ID: 28732558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The need for precision nutrition, genetic variation and resolution in Covid-19 patients.
    Simopoulos AP; Serhan CN; Bazinet RP
    Mol Aspects Med; 2021 Feb; 77():100943. PubMed ID: 33551236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers.
    Serhan CN; Arita M; Hong S; Gotlinger K
    Lipids; 2004 Nov; 39(11):1125-32. PubMed ID: 15726828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolvins and protectins: mediating solutions to inflammation.
    Kohli P; Levy BD
    Br J Pharmacol; 2009 Oct; 158(4):960-71. PubMed ID: 19594757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids].
    Nowak JZ
    Postepy Hig Med Dosw (Online); 2010 Mar; 64():115-32. PubMed ID: 20354260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.